- from the UK MHRA. On June 9, 2010,
Astellas acquired OSI
Pharmaceuticals for $4.0 billion. In
December 2014,
Astellas expanded its 18-month-old collaboration...
- and scientist,
currently Head of
Astellas Global Regenerative Medicine, and
Chief Scientific Officer of the
Astellas Institute for
Regenerative Medicine...
-
Astellas Institute for
Regenerative Medicine is a
subsidiary of
Astellas Pharma located in Marlborough, M****achusetts, US,
developing stem cell therapies...
-
Results of
Astellas for
Fiscal Year 2023" (PDF). "Financial
Results of
Astellas for
Fiscal Year 2022" (PDF). "Financial
Results of
Astellas for Fiscal...
-
fully humanized antibody was
created by
scientists at
Agensys (part of
Astellas)
using Xenomice from Amgen; the
linker technology holding the antibody...
- (Leuprorelin), for
prostate cancer,
marketed by
Astellas.
Flomax (Tamsulosin), for
bladder relief,
marketed by
Astellas. The
company also
produces a
broad range...
- from this source,
which is in the
public domain. "
Astellas to
Acquire Ogeda SA" (Press release).
Astellas Pharma.
Archived from the
original on 5 November...
- Italy,
Russia and Iceland, it is
marketed under the
trade name
Omnic by
Astellas Pharma Europe. The
largest manufacturer of
tamsulosin is
Synthon BV (the...
-
December 2013.
Retrieved 20
December 2013. "
Astellas Completes Acquisition of
Ganymed Pharmaceuticals".
Astellas Pharma.
Archived from the
original on 5 August...
-
product pipeline includes enfortumab vedotin,
being co-developed with
Astellas Pharma,
tisotumab vedotin,
being co-developed with Genmab, SGN-LIV1A, an...
